The Biopinion, in Biophotonics Nov-Dec 2022 issue, discusses the problem "Medical research has a long, unfortunate track record of excluding ethnic and racial minority groups from clinical trials... [...] This has led to increased morbidity and mortality in minority groups. [...] We found that industry-sponsored trials (as opposed to investigator-initiated ones) were significantly less likely to include people of color than non-industry-sponsored trials." USA study. By Akshay Pulavarty.